[HTML][HTML] Efficacy of baricitinib in the treatment of chilblains associated with Aicardi‐Goutières syndrome, a type I interferonopathy
K Meesilpavikkai, WA Dik, B Schrijver… - Arthritis & …, 2019 - ncbi.nlm.nih.gov
K Meesilpavikkai, WA Dik, B Schrijver, CG van Helden‐Meeuwsen, MA Versnel…
Arthritis & Rheumatology (Hoboken, Nj), 2019•ncbi.nlm.nih.gov5. Rice GI, Forte GM, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS, et al.
Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with
mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a
casecontrol study. Lancet Neurol 2013; 12: 1159–69.
Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with
mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a
casecontrol study. Lancet Neurol 2013; 12: 1159–69.
5. Rice GI, Forte GM, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS, et al. Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a casecontrol study. Lancet Neurol 2013; 12: 1159–69.
ncbi.nlm.nih.gov
